Early atherosclerosis in human hypertension

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 882-883

  Simon, Alain ^a   Megnien, Jean Louis ^a   Gariepy, Jérôme ^a   Levenson, Jaime ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Atherosclerosis; Complications; Early detection; Hypertension

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ATHEROSCLEROSIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS;

ARTERIES; ARTERIOSCLEROSIS; CALCINOSIS; HUMANS; HYPERTENSION; TIME FACTORS;

EID: 0032127210     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00076-4     Document Type: Conference Paper

References (7)

1. 1. Gariepy J, Massonneau M, Levenson J, et al, and the PCVMETRA Group: Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993;22:111-118.
2. 2. Simon A, Giral P, Levenson J: Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in symptomatic men: association with coronary risk profile. Circulation 1995;92:1414-1421.
3. 3. Megnien JL, Simon A, Lemariey M, et al: Hypertension promotes coronary calcium deposit in asymptomatic men. Hypertension 1996;27:949-954.
4. 4. Levenson J, Simon A, Cambien F, Berretti C. Cigarette smoking and hypertension. Factors independently associated with blood hyperviscosity and arterial rigidity. Arteriosclerosis 1987;7:572-578.
5. 5. Armentano R, Megnien JL, Simon A, et al: Effects of hypertension on viscoelasticity of carotid and femoral arteries in human. Hypertension 1995;26:48-54.
6. 6. Simon A, Levenson J: Could the identification of subclinical atherosclerosis offer an alternative to the mass drug treatment of hypercholesterolemia? Atherosclerosis 1994;105:245-249.
7. 7. Simon A, Gariepy J, Provost JC, et al, on behalf of the IMT-INSIGHT Group. Nifedipine, hypertension, and arterial wall thickening in extracoronary arteries: design features of a clinical trial using noninvasive ultrasound end points. J Cardiovasc Pharmacol 1996;28(suppl 3):27-32.